Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (7): 830-836.
Previous Articles Next Articles
WANG Yan1, BU Wen-ting2, LI Peng-fei1, MA Ping1, GAO Wen-jing1, SUN Jian-zi1
Received:
2011-03-30
Revised:
2011-06-24
Online:
2011-07-26
Published:
2011-09-22
CLC Number:
WANG Yan, BU Wen-ting, LI Peng-fei, MA Ping, GAO Wen-jing, SUN Jian-zi. Advancement of the drug monitoring methods of immunodepressants in human blood[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 830-836.
[1] 程抗, 张晓菲, 宋蔚. 免疫抑制剂临床应用新进展[J]. 中国医药导刊, 2008, 10(8): 1204-1205. [2] 潘春树,何雪菲, 钱华. 常用免疫抑制剂的作用机制及应用[J].安徽医药, 2008, 12(10) : 892-894. [3] 夏东亚, 郭涛, 蒋苓, 等. ELISA法监测肝移植患者他克莫司全血浓度[J].中国临床药理学与治疗学,2006, 11(8): 933-936. [4] 邹德琴, 王小中, 魏筱华,等. MEIA法测定他克莫司全血浓度的问题分析[J]. 实用临床医学, 2008, 9(10): 16-17. [5] 叶伟民, 陆慧琦, 朱烨, 等. 他克莫司在临床检测中的方法学比较[J].现代检验医学杂志, 2008, 23(2): 85-87. [6] 丁春雷, 刘丽宏, 马萍, 等. 他克莫司治疗药物监测研究进展[J].中国药房, 2008, 19(20): 1580-1582. [7] 李鹏飞, 刘丽宏, 马 萍, 等. 高效液相色谱-串联质谱法在他克莫司临床血药浓度监测中的应用[J]. 质谱学报, 2008, 29(3): 137-143. [8] Chena YL, Hirabayashi H, Akhtar S, et al. Simultaneous determination of three isomeric metabolites of tacrolimus(FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Anslyt Technol Biomed Life Sci,2006,830(2): 330-341. [9] 丁慧, 董振南, 贾兴旺, 等.他克莫司血药浓度的方法学评价[J]. 标记免疫分析与临床, 2010,17(4):264-265. [10] 梁陈方, 王亚洲.反相高效液相色谱法测定他克莫司的血药浓度[J]. 广西医学,2009, 31(3): 425-426. [11] 刘文豹, 刘增, 牛德森, 等. 环孢素A血药浓度监测方法比较分析[J]. 标记免疫分析与临床, 2006, 13(3):188. [12] 宋丽丽, 陈东生, 吕永宁. 环孢素血药浓度监测方法比较[J]. 医药导报,2008,27(2):210-212. [13] 戴志凌, 帅莉, 苏琴. 单克隆荧光偏振免疫法和高效液相色谱法测定环孢素A全血浓度的相关性[J]. 药物研究, 2008, 17 (21): 16-18. [14] McBride JH,Kim S,Rodgerson DO,et al.Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclona1)to an FPIA(monoclona1) technique for measurement of blood cyclosporin A[J].J Clin Lab Anal,1998,12(6): 337-340. [15] 章秀兰, 顾志冬, 施新明, 等. 高效毛细管电泳法检测血中环孢素A浓度[J].诊断学理论与实践, 2004, 3(4): 280-286. [16] 刘晓, 李凯鹏, 李朋梅, 等. 反相高效液相紫外法测定人全血中环孢素A含量[J].中日友好医院学报, 2008, 22(5): 307-308. [17] 赵驻军, 张翠欣, 李亚, 等. 高效液相色谱法检测人全血环孢素A浓度[J]. 河北医药, 2006, 28(10): 995-996. [18] Zaater MF,Tahboub YR,Najib NM.Liquid chromatographic-electrospray mass spectrometric determination of cyclosporin A in human plasma[J]. Anal Bioanal Chem, 2005, 382(1): 223-230. [19] Vollenbroeker B, Koch JH, Fobker M, et al. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters[J]. Transplant Proc, 2005, 37(4): 1741-1744. [20] Wang GF, Hsieh Y, Korfmacher WA. Comparison of atmospheric pressure chemical ionization, electrospray ionization, and atmospheric pressure photoionization for the determination of cyclosporin A in rat plasma[J]. Anal Chem, 2005, 77(2): 541-548. [21] Roberts NB, Dutton J, Higgins G, et al. Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TD[J]. Clin Chem Lab Med, 2005, 43(2): 228-236. [22] Hatsis P, Volmer DA.Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 809(2): 287-294. [23] Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry(LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine[J]. Ther Drug Monit, 2005, 27(2): 144-150. [24] Small DS, Acheampong A, Reis B, et al. Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease[J].J Ocul Pharmacol Ther,2002, 18(5):411-418. [25] 王淑民, 李鹏飞, 赵秀丽,等. LC-MS/MS法测定人全血中环孢素A浓度及环孢素眼用乳剂健康人体药代动力学研究[J]. 质谱学报, 2010, 31(1): 53-58. [26] 任斌, 李敏薇, 唐蕾, 等.高效液相色谱法快速测定霉酚酸血药浓度[J]. 中国医院药学杂志, 2008, 28(5): 407-408. [27] 师少军, 李忠芳, 万元胜, 等. HPLC法测定人血浆中霉酚酸的浓度及药动学研究[J]. 中国药房, 2007, 18(20): 1558-1560. [28] 叶丽卡, 谢志红, 王若伦, 等. HPLC法测定肾移植患者血浆中霉酚酸的浓度[J].中国药房, 2008, 19(17): 1306-1308. [29] 南峰, 余勤, 梁茂植, 等. RP-HPLC法测定肾移植病人血浆中霉酚酸浓度及其应用[J]. 药物分析杂志, 2004, 24(3): 275-278. [30] 王晓红, 杨淑敏. 高效液相色谱法测定患者血浆中霉酚酸浓度[J].中国冶金工业医学杂志, 2008, 25(5): 531-532. [31] 胡咏华, 裴奇. 高效液相色谱法测定人血浆中霉酚酸的浓度[J]. 中南药学, 2009, 7(2): 317-319. [32] 郑国钢, 郑怀宇, 郑金琪, 等. 高效液相色谱-质谱联用法测定人血浆中霉酚酸的浓度[J].中国医院药学杂志, 2008, 28(7): 522-525. [33] 罗志刚, 唐孝达, 邓显昭, 等. 内源性糖皮质激素浓度测定在肾移植中的意义[J]. 华西医学, 1997, 12(1): 107-109. [34] 夏运成, 张旭光, 李江, 等. HPLC法测定强的松的血药浓度及其临床应用价值[J]. 医学临床研究, 2006, 23(8): 1213-1216. [35] Ionita IA, Fast DM, Akhlaghi F, et al.Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma[J]. J Chromatogra B Analyt Technol Biomed Life Sci,2009, 877 (8/9): 765-772. [36] Shibasaki H , Nakayama H, Furuta T, et al. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: Estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy[J]. J Chromatogr B Analyt Technol Biomed Life Sci ,2008,870 (2): 164-169. [37] 董振南, 贾兴旺, 王玲, 等. 微粒子酶联免疫吸附法测定西罗莫司血药浓度的方法学评价[J]. 军医进修学院学报, 2006, 27(5): 366-367. [38] 李月霞, 张弋, 付鹏. 肾移植1例的西罗莫司全血浓度监测[J].临床和实验医学杂志, 2010, 9(7): 554-555. [39] 李敏薇, 任斌, 张志豪, 等.高效液相色谱法快速测定西罗莫司血药浓度[J].中国医院药学杂志[J] , 2008, 28(9): 760-761. [40] 黎曙霞, 任斌, 王长希, 等.固相萃取-HPLC法测定西罗莫司的血药浓度及其临床应用研究[J].中国药房, 2008, 19(20): 1540-1542. [41] 张东娣, 范艳花. 液-质联用在西罗莫司和依维莫司血药浓度监测中的应用进展[J].商丘师范学院学报, 2007, 23(12): 90-93. [42] 祝仕清, 牛长群, 耿亚鹏. UPLC(超高效液相色谱)/MS /MS联用技术测定全血中的西罗莫司[J].中国抗生素杂志, 2007, 32(6): 347-349. [43] Difrancesco R, Frerichs V, Donnelly J, et al.Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolicacid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2007,859(1):42-51. [44] Bogusz MJ, Enazi EA, Hassan H, et al. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 850(1/2): 471-480. [45] Ansermot N, Fathi M, Veuthey JL, et al. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospraymass spectrometry[J].Clin Biochem,2008,41(9):728-735. [46] Op den Buijsch RA, Christiaans MH, Stolk LM, et al.Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1(ABCB1) and cytochrome (CYP)3A polymorphisms[J]. Fundam Clin Pharmacol, 2007, 21(4):427-435. [47] Macphee IA, Fredericks S, Tai T,et al.The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation[J]. Am J Transplant, 2004, 4(6): 914-919. [48] Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine[J]. Ther Drug Monit,2005, 27(2): 144-150. [49] Hatsis P, Volmer DA. Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2004, 809(2): 287-294. [50] Streit F, Armstrong VW, Oellerich M.Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood[J].Clin Chem,2002, 48(6 pt 1): 955-958. [51] Deters M, Kirchner G, Resch K, et al. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS) [J].Clin Chem Lab Med,2002, 40(3): 285-295. [52] Taylor PJ, Salm P, Lynch SV, et al. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry[J].Ther Drug Monit,2000, 22(5): 608-612. |
[1] | WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan. Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145. |
[2] | HE Jie, LIU Dongxue, ZHONG Lingjun, SHAO Hua, HU Linlin. Establishment of a limited sampling strategy to estimate micafungin exposure in critically ill patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1264-1271. |
[3] | PENG Min, HUANG Panhao, DENG Yinhua, LIU Wen, LI Wei, YU Zhen, XIA Qing, XIE Yueliang. Analysis of influence factors of voriconazole trough concentration in patients with hematopoietic stem cell transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 640-646. |
[4] | ZHANG Siliang, HU Linlin, SHAO Hua, CHEN Xijing. Research progress on the influence of sex differences on the action of psychotropic drugs#br# [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 324-331. |
[5] | ZHANG Lu, LIN Liangmo, LIU Keke, HUANG Yamin, HUANG Xingxing, YANG Yongyu, XIAO Jian. Therapeutic drug monitoring and pharmacokinetics of new coronavirus pneumonia antiviral drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 566-575. |
[6] | YAN Lin, WANG Jingjing, HUANG Hua, YAO Qin, LI Qian, ZHANG Jun. Application of immunosuppressive agents in pregnancy after organ transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1317-1320. |
[7] | DING Zhirong, CAI Xiaozhen, ZENG Haiwen, LIN Tianlai. Population pharmacokinetics of vancomycin in post-operative neurosurgical patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1252-1257. |
[8] | ZHANG Chao . Pharmacodynamic studies evaluation of voriconazole [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 116-120. |
[9] | ZHAN Ying, SHU Nan, GUO Nan, SHAO Hua, LI Wei-lan. Advances in therapeutic drug monitoring for triazole antifungal agents [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 706-711. |
[10] | LI Hao, WANG Xue, DONG Hai-yan, DONG Ya-lin, TIAN Gang. Clinical analysis of therapeutic drug monitoring and drug dosage for ICU patients treated with teicoplanin [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 538-544. |
[11] | LI Peng-fei, LIU Li-hong, MA Ping, DING Chun-lei, TONG Wei-hang. Comparison on two methods of HPLC-MS/MS and MEIA in monitoring the tacrolimus concentrations for organ transplantation patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 80-83. |
[12] | JIA Yuan-wei, XIE Hai-tang, WANG Guang-ji. Development and validation of a liquid chromatographic electrospray ionization mass spectrometric method for the determination of digoxin in human plasma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(12): 1422-1425. |
[13] | ZHANG Shen, WANG Li, LIU Ying. Correlation of lamotrigine concentrations between saliva and serum in children with epilepsy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(9): 978-982. |
[14] | LIU Ying, WANG Li, HE Da-ke. Simultaneous determination of carbamazepine, lamotrigine, phenobarbital, phenytoin and 10, 11-carbamazepine epoxide in serum by reversedphase high performance liquid chromatography [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 846-851. |
[15] | HE Xi-Mei, LIU Xue-Wu, LI Xun-Xia. Current researches of clinical individualized medication and their evaluation1 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 237-240. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||